SpyGlass Pharma, Inc.
SGP$625M
Small CapNASDAQSurgical & Medical Instruments & Apparatus🇺🇸North AmericaALISO VIEJO
Drugs in Pipeline
3
Phase 3 Programs
2
Upcoming Catalysts
2
Next Catalyst
Jun 25, 2026
5dMarket Overview
Stock performance and key metrics
SGP News
Catalyst Timeline
2 upcoming, 0 past
EarningsNext
SGP Earnings Report
Jun 25, 2026Confirmed
EPS Est: $-0.67 | FQ end 2026-03
1 more catalyst beyond 14 days
Start a 48-hour free trial to see all upcoming catalysts
Drug Pipeline
Bimatoprost Implant System
Cataract
Timolol Maleate Ophthalmic Solution, 0.5%
Cataract
Bimatoprost Implant System (High Dose)
Cataract
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Bimatoprost Implant System | Phase 3 | Cataract | - | - |
Timolol Maleate Ophthalmic Solution, 0.5% | Phase 3 | Cataract | - | - |
Bimatoprost Implant System (High Dose) | Phase 2 | Cataract | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply